Overview

Infusion Pumps Market Introduction:

The infusion pumps market is estimated to surpass US$ 20 billion by 2027 end at a CAGR of 6.5% from 2020 to 2027.

An infusion pump is a medical device (syringe, peristaltic among others) used for delivering fluids in disease management; usually the nutrients, drugs. They include a continuous infusion pump, intermittent infusion, patient-controlled infusion and total parenteral nutrition infusions. The most common application is to maintain appropriate fluid levels and it also used for supplying nutrients to support life & to maintain growth & development in paediatric patients. Infusion pumps have a wide range of application in healthcare setting.

Market Overview:

Infusion pumps have a huge application in primary healthcare settings for fluid management. An increasing prevalence of medical conditions requires continuous fluid management. Because of this, there is a huge demand for infusion pumps in end users segment and led to the potential growth of infusion pump market. Further, changing regulatory scenarios to control the medical errors led to development of stringent regulations. These regulations are focused on controlling safety issues associated with infusion management. Other factors like raising awareness and advancing healthcare services to maintain the quality of life led to robust growth of the market.

Infusion pumps market is majorly driven by high adoption among the end user segment. North America and Europe Infusion Pumps markets account major share in the global market and are expected to remain dominant throughout the forecast period. Asia Pacific region represents the most lucrative market for infusion pumps manufacturers due to the patient population. It represents the highest growth rate during the forecast period. Latin America and Rest of the world represents a small fraction in global market due to less penetration and expected to register significant CAGR during the forecast period.

Major players include:

Johnson & Johnson, Baxter, B. Braun, CareFusion, Covidien, Fresenius Kabi, Hospira, I-Flow, Ypsomed Holding, Micrel Medical Devices SA, Roche Diagnostics, Smiths Medical and others. Manufacturers are majorly focused on vertical integration through collaboration and partnerships to enhance the market reach and product portfolio of the company.

Infusion Pumps Market Segmentation:

By Product Type

Ambulatory Infusion Pumps
Implantable Infusion Pumps
Syringe Pumps
Volumetric Pumps
Elastomeric infusion pump
Enteral pump
Disposable Sets & Accessories

By End-User

Hospital
Clinics
Outpatient Centre
Long Term Care Centre
Homecare Settings
Rehabilitation Centre

By Application

Chemotherapy/Oncology
Diabetes
Gastroenterology
Analgesia/Pain Management
Pediatrics/Neonatology
Hematology
Other Applications

By Region

Europe
North America
APAC
Latin America
Rest of World

Competitive Landscape:

Tier 1 players- established companies in the market with a major market share
Tier 2 players
Emerging players which are growing rapidly
New Entrants

FutureWise Takeaways:

Growth prospects
SWOT analysis
Key trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global infusion pumps market on the basis of product type, end-user and region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and an overall market
To predict the market size, in key regions (along with countries)—North America, Europe, Asia Pacific, Latin America, and the Middle East
To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
Profiling of companies to evaluate their market shares, strategies, financials and core competencies